Keppra

Keppra is an antiepileptic drug containing the active ingredient levetiracetam, developed by UCB Pharma SA, a Belgian company. It is used to treat various types of seizures in patients aged one month and older. The drug is manufactured in multiple countries to meet global demand. UCB Pharma SA remains the ultimate owner of the Keppra brand, overseeing its production and distribution worldwide.